CLASS II Device recall · Reported 2 Jun 2021 · FDA Enforcement Report

Access Sars-CoV-2 Antigen recalled by Beckman Coulter

Beckman Coulter is recalling Access Sars-CoV-2 Antigen, distributed nationwide in the US. The recall was initiated on 14 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lots
Quantity recalled1,034 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1670-2021
FDA event ID
87738
Recalling firm
Beckman Coulter, Brea, CA
Classification
Class II
Status
Terminated
Recall initiated
14 Apr 2021
FDA classified
21 May 2021
Reported
2 Jun 2021
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

14 Apr 2021Recall initiated by company
21 May 2021Classified by FDA+37 days
2 Jun 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

specimens collected in transport media may result is false negative results when stored in certain conditions.

Product as listed by the FDA

Access SARS-CoV-2 Antigen, REF C68668, UDI: (01)15099590742713, 3.30 mL/R1a, 4.70 mL/R1b, 4.20 mL/R1c, 3.10 mL, R1d, 3.10 mL, R1e

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of Alabama, Arizona, Arkansas, California, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Tennessee, Texas, Virginia, West Virginia and the country of New Zealand.

Nationwide AlabamaArkansasArizonaCaliforniaConnecticutDelawareFloridaGeorgiaIowaIdahoIllinoisIndianaKentuckyLouisianaMassachusettsMarylandMaineMichiganMississippiNorth Carolina

Questions about this recall

Is Access Sars-CoV-2 Antigen recalled?

Yes. Beckman Coulter recalled Access Sars-CoV-2 Antigen on 14 Apr 2021. The recall is Class II and its status is Terminated. Recall number Z-1670-2021.

Why was it recalled?

specimens collected in transport media may result is false negative results when stored in certain conditions.

Which lots are affected?

All Lots

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of Alabama, Arizona, Arkansas, California, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Tennessee, Texas, Virginia, West Virginia and the country of New Zealand.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Beckman Coulter

All 334

Other Test Kits & Diagnostics recalls

All 2,656